Intramyocardial injection of autologous bone marrow mononuclear cells for patients with chronic ischemic heart disease and left ventricular dysfunction (First Mononuclear Cells injected in the US [FOCUS]): Rationale and design

American Heart Journal

Volumn 160, Issue 2, 2010, Pages 215-223

  Willerson, James T ^a,b   Perin, Emerson C ^a   Ellis, Stephen G ^a   Pepine, Carl J ^a   Henry, Timothy D ^a   Zhao, David X M ^a   Lai, Dejian ^a   Penn, Marc S ^a   Byrne, Barry J ^a   Silva, Guilherme ^a   Gee, Adrian ^a   Traverse, Jay H ^a   Hatzopoulos, Antonis K ^a   Forder, John R ^a   Martin, Daniel ^a   Kronenberg, Marvin ^a   Taylor, Doris A ^a   Cogle, Christopher R ^a   Baraniuk, Sarah ^a   Westbrook, Lynette ^a   Sayre, Shelly L ^a   Vojvodic, Rachel W ^a   Gordon, David J ^a   Skarlatos, Sonia I ^a   Moyé, Lemuel A ^a   Simari, Robert D ^a   more..

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOLOGOUS BONE MARROW MONONUCLEAR CELL; AUTOLOGOUS STEM CELL TRANSPLANTATION; BLOOD CELL COUNT; BONE MARROW CELL; CELL LINE; CHRONIC DISEASE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; DEMOGRAPHY; ELECTROCARDIOGRAM; FOLLOW UP; HEART FUNCTION; HEART LEFT VENTRICLE CONTRACTILITY; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE CELL; HEART MUSCLE OXYGEN CONSUMPTION; HEART MUSCLE PERFUSION; HEART VENTRICLE WALL MOTION; HOLTER MONITORING; HUMAN; ISCHEMIC HEART DISEASE; LIVER FUNCTION; MAJOR CLINICAL STUDY; MEDICAL HISTORY; MONONUCLEAR CELL; MUSCLE CELL; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT SAFETY; PHYSICAL EXAMINATION; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; REVIEW; RISK ASSESSMENT; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STATISTICS; STUDY DESIGN; TREADMILL EXERCISE; TREATMENT OUTCOME; TREATMENT PLANNING;

EID: 77955445600     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2010.03.029     Document Type: Article

References (34)

1. Rosamond W., Flegal K., and Friday G. Heart disease and stroke statistics-2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee Circulation 115 2007 e69 e171
2. Ford E.S., Ajani U.A., and Croft J.B. Explaining the decrease in U.S. deaths from coronary disease, 1980-2000 N Engl J Med 356 2007 2388 2398
3. Levy D., Kenchaiah S., and Larson M.G. Long-term trends in the incidence of and survival with heart failure N Engl J Med 347 2002 1397 1402 (Pubitemid 35239711)
4. Roger V.L., Weston S.A., and Redfield M.M. Trends in heart failure incidence and survival in a community-based population JAMA 292 2004 344 350
5. Simari R.D., Moyé L.A., and Skarlatos S.I. Development of a network to test strategies in cardiovascular cell delivery: the NHLBI-sponsored Cardiovascular Cell Therapy Research Network (CCTRN) J Cardiovasc Transl Res 3 2010 30 36
6. Hughes S. Cardiac stem cells J Pathol 197 2002 468 478
7. Fuchs S., Baffour R., and Zhou Y.F. Transendocardial delivery of autologous bone marrow enhances collateral perfusion and regional function in pigs with chronic experimental myocardial ischemia J Am Coll Cardiol 37 2001 1726 1732
8. Hamano K., Li T.S., and Kobayashi T. Therapeutic angiogenesis induced by local autologous bone marrow cell implantation Ann Thorac Surg 73 2002 1210 1215 (Pubitemid 34279405)
9. Kamihata H., Matsubara H., and Nishiue T. Implantation of bone marrow mononuclear cells into ischemic myocardium enhances collateral perfusion and regional function via side supply of angioblasts, angiogenic ligands, and cytokines Circulation 104 2001 1046 1052
10. Kocher A.A., Schuster M.D., and Szabolcs M.J. Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function Nat Med 7 2001 430 436
11. Gunsilius E., Duba H.C., and Petzer A.L. Evidence from a leukaemia model for maintenance of vascular endothelium by bone-marrow-derived endothelial cells Lancet 355 2000 1688 1691
12. Orlic D., Kajstura J., and Chimenti S. Bone marrow cells regenerate infarcted myocardium Nature 410 2001 701 705
13. Tomita S., Li R.K., and Weisel R.D. Autologous transplantation of bone marrow cells improves damaged heart function Circulation 100 1999 II247 II256
14. Seeger F.H., Tonn T., and Krzossok N. Cell isolation procedures matter: a comparison of different isolation protocols of bone marrow mononuclear cells used for cell therapy in patients with acute myocardial infarction Eur Heart J 28 2007 766 772
15. Zhang S., Wang D., and Estrov Z. Both cell fusion and transdifferentiation account for the transformation of human peripheral blood CD34-positive cells into cardiomyocytes in vivo Circulation 110 2004 3803 3807
16. Zhang S., Shpall E., and Willerson J.T. Fusion of human hematopoietic progenitor cells and murine cardiomyocytes is mediated by α4β1 integrin/vascular cell adhesion molecule-1 interaction Circ Res 100 2007 693 702
17. + -enriched cell population into cardiomyocytes, endothelial cells, and smooth muscle cells In Vivo Circulation 108 2003 2070 2073
18. Assmus B., Schächinger V., and Teupe C. Transplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AMI) Circulation 106 2002 3009 3017
19. Erbs S., Linke A., and Schächinger V. Restoration of microvascular function in the infarct-related artery by intracoronary transplantation of bone marrow progenitor cells in patients with acute myocardial infarction. The Doppler Substudy of the Reinfusion of Enriched Progenitor Cells and Infarct Remodeling in Acute Myocardial Infarction (REPAIR-AMI) Trial Circulation 116 2007 366 374
20. Meyer G.P., Wollert K.C., and Lotz J. Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months' follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) trial Circulation 113 2006 1287 1294
21. Schächinger V., Erbs S., and Elsässer A. Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction N Engl J Med 355 2006 1210 1221
22. Strauer B.E., Brehm M., and Zeus T. Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans Circulation 106 2002 1913 1918
23. Wollert K.C., Meyer G.P., and Lotz J. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial Lancet 364 2004 141 148
24. Assmus B., Fischer-Rasokat U., and Honold J. Transcoronary transplantation of functionally competent BMCs is associated with a decrease in natriuretic peptide serum levels and improved survival of patients with chronic postinfarction heart failure: results of the TOPCARE-CHD Registry Circ Res 100 2007 1234 1241
25. Tse H.F., Kwong Y.L., and Chan J.K. Angiogenesis in ischaemic myocardium by intramyocardial autologous bone marrow mononuclear cell implantation Lancet 361 2003 47 49
26. van Ramshorst J., Bax J.J., and Beeres S.L.M.A. Intramyocardial bone marrow cell injection for chronic myocardial ischemia: a randomized controlled trial JAMA 301 2009 1997 2004
27. Perin E.C., Dohmann H.F.R., and Borojevic R. Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure Circulation 107 2003 2294 2302
28. Perin E.C., Dohmann H.F., and Borojevic R. Improved exercise capacity and ischemia 6 and 12 months after transendocardial injection of autologous bone marrow mononuclear cells for ischemic cardiomyopathy Circulation 110 11 Suppl 1 2004 II213 II218
29. Aktas M., Radke T.F., and Strauer B.E. Separation of adult bone marrow mononuclear cells using the automated closed separation system Sepax Cytotherapy 10 2008 203 211
30. Lang R.M., Bierig M., and Devereux R.B. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology J Am Soc Echocardiogr 18 2005 1440 1463
31. Bangdiwala S.I., Weiner D.H., and Bourassa M.G. (1992). Studies of Left Ventricular Dysfunction (SOLVD) Registry: rationale, design, methods and description of baseline characteristics Am J Cardiol 70 1992 347 353
32. Bursi F., Weston S.A., and Redfield M.M. Systolic and diastolic heart failure in the community JAMA 296 2006 2209 2216
33. Owan T.E., Hodge D.O., and Herges R.M. Trends in prevalence and outcome of heart failure with preserved ejection fraction N Engl J Med 355 2006 251 259
34. Yancy C.W., Lopatin M., and Stevenson L.W. Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function: a report from the Acute Decompensated Heart Failure National Registry (ADHERE) Database J Am Coll Cardiol 47 2006 76 84